blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP1773859

EP1773859 - METHODS AND COMPOSITIONS FOR THE INHIBITION OF GENE EXPRESSION [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  08.10.2010
Database last updated on 14.11.2024
Most recent event   Tooltip08.10.2010Application deemed to be withdrawnpublished on 10.11.2010  [2010/45]
Applicant(s)For all designated states
Pronai Therapeutics, Inc.
4717 Campus Drive, Suite 1100
Kalamazoo, MI 49008-5605 / US
[N/P]
Former [2007/16]For all designated states
Pronai Therapeutics, Inc.
4717 Campus Drive Suite 1100
Kalamazoo MI 49008-5605 / US
Inventor(s)01 / SHEIKHNEHJAD, Gholamreza
6394 Bedview Drive
Salie, MI 48176 / US
02 / SOOCH, Mina, Patel
6894 Lakemont Circle
W. Bloomfield, MI 48323 / US
03 / GOODWIN, Neal
120 109th Avenue
Plainwell, MI 49080 / US
04 / OLSON, David
3303 The Glade Street
Ann Arbor, MI 48103 / US
 [2007/16]
Representative(s)Cohausz & Florack
Patent- & Rechtsanwälte
Partnerschaftsgesellschaft mbB
Bleichstraße 14
40211 Düsseldorf / DE
[N/P]
Former [2008/31]Cohausz & Florack
Patent- und Rechtsanwälte Bleichstrasse 14
40211 Düsseldorf / DE
Former [2007/16]Cohausz & Florack
Patent- und Rechtsanwälte Bleichstrasse 14
40211 Düsseldorf / DE
Application number, filing date05804859.601.06.2005
[2007/16]
WO2005US18993
Priority number, dateUS2004085801301.06.2004         Original published format: US 858013
US2004085809401.06.2004         Original published format: US 858094
US2004085814501.06.2004         Original published format: US 858145
US2004085814601.06.2004         Original published format: US 858146
US2004085816401.06.2004         Original published format: US 858164
US2004085834101.06.2004         Original published format: US 858341
US20040611974P22.09.2004         Original published format: US 611974 P
US20040637212P17.12.2004         Original published format: US 637212 P
[2007/16]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report
No.:WO2005118824
Date:15.12.2005
Language:EN
[2005/50]
Type: A2 Application without search report 
No.:EP1773859
Date:18.04.2007
Language:EN
The application published by WIPO in one of the EPO official languages on 15.12.2005 takes the place of the publication of the European patent application.
[2007/16]
Search report(s)International search report - published on:US25.01.2007
(Supplementary) European search report - dispatched on:EP22.02.2008
ClassificationIPC:C07H21/02, C07H21/04
[2007/16]
CPC:
C12N15/1135 (EP,US); A61K31/70 (EP,US); A61P35/00 (EP);
A61P35/02 (EP); A61K48/00 (EP,US); C12N2310/11 (EP,US);
C12N2310/3341 (EP,US) (-)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   MC,   NL,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2007/16]
Extension statesALNot yet paid
BANot yet paid
HRNot yet paid
LVNot yet paid
MKNot yet paid
YUNot yet paid
TitleGerman:VERFAHREN UND ZUSAMMENSETZUNGEN ZUR GENEXPRESSIONSHEMMUNG[2007/16]
English:METHODS AND COMPOSITIONS FOR THE INHIBITION OF GENE EXPRESSION[2007/16]
French:METHODES ET COMPOSITIONS INHIBANT L'EXPRESSION GENIQUE[2007/16]
Entry into regional phase29.12.2006National basic fee paid 
29.12.2006Search fee paid 
29.12.2006Designation fee(s) paid 
29.12.2006Examination fee paid 
Examination procedure29.12.2006Examination requested  [2007/16]
09.03.2007Amendment by applicant (claims and/or description)
05.12.2008Despatch of a communication from the examining division (Time limit: M06)
24.09.2009Reply to a communication from the examining division
13.11.2009Despatch of a communication from the examining division (Time limit: M06)
26.05.2010Application deemed to be withdrawn, date of legal effect  [2010/45]
25.06.2010Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time  [2010/45]
Divisional application(s)EP09171679.5  / EP2141173
Request for further processing for:The application is deemed to be withdrawn due to failure to reply to the examination report
24.09.2009Request for further processing filed
24.09.2009Full payment received (date of receipt of payment)
Fees paidRenewal fee
27.06.2007Renewal fee patent year 03
25.06.2008Renewal fee patent year 04
19.06.2009Renewal fee patent year 05
Penalty fee
Additional fee for renewal fee
30.06.201006   M06   Not yet paid
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[X]WO03040182  (VISUFARMA S R L [IT], et al) [X] 1 * page 2 - page 5 *;
 [PX]WO2004056971  (GENTA INC [US], et al) [PX] 1 * page 13 - page 14 *;
 [X]  - XODO L E ET AL, "ANTI-GENE STRATEGIES TO DOWN-REGULATE GENE EXPRESSION IN MAMMALIAN CELLS", CURRENT PHARMACEUTICAL DESIGN, BENTHAM SCIENCE PUBLISHERS, SCHIPHOL, NL, (200403), vol. 10, no. 7, ISSN 1381-6128, pages 805 - 819, XP009083431 [X] 1-96 *the whole document, in particular: p. 806, right column, second paragraph, p. 808, right column, second paragraph, fig.5, p. 812, right column, paragraph spanning pages*

DOI:   http://dx.doi.org/10.2174/1381612043452983
 [A]  - REED J C, "Promise and problems of Bcl-2 antisense therapy.", JOURNAL OF THE NATIONAL CANCER INSTITUTE 16 JUL 1997, (19970716), vol. 89, no. 14, ISSN 0027-8874, pages 988 - 990, XP002468189 [A] * the whole document *

DOI:   http://dx.doi.org/10.1093/jnci/89.14.988
 [A]  - PUTNAM D A, "ANTISENSE STRATEGIES AND THERAPEUTIC APPLICATIONS", AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, (19960115), vol. 53, no. 2, ISSN 1079-2082, pages 151 - 160,182, XP000603121 [A] 1-96 * the whole document *
 [A]  - WARZOCHA K ET AL, "ANTISENSE STRATEGY: BIOLOGICAL UTILITY AND PROSPECTS IN THE TREATMENT OF HEMATOLOGICAL MALIGNANCIES", LEUKEMIA AND LYMPHOMA, HARWOOD ACADEMIC PUBLISHERS, CHUR, CH, (199701), vol. 24, no. 3/4, ISSN 1042-8194, pages 267 - 281, XP000983227 [A] 1-96 * the whole document *
International search[Y]US5792608  (SWAMINATHAN SUNDARAMOORTHI [US], et al);
 [X]WO9814172  (UNIV TEXAS [US], et al)
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.